Flemingsberg Science Foundation at Almedalen

We at the foundation have spent a sunny week in Almedalen 2024. It was a week filled with many insights and exciting discussions, and a highlight for us was our roundtable discussion, which we organized together with Huddinge Municipality. There, we delved into Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. Pernilla Boström, COO of the Flemingsberg Science Foundation, shares more.

“It was very inspiring to lead and participate in the roundtable discussion we organized together with Huddinge Municipality about Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. Sharing insights and experiences with a group of wise individuals from different perspectives was extremely rewarding.”

“I left Almedalen tired and satisfied, with many new impressions. I have had the privilege to participate, contribute, and be inspired alongside colleagues and partners. It has been a bustling exchange of knowledge, opportunities to influence and make a difference, and generous conversations and meetings – both formal and informal. The days were long, but I am already looking forward to next year’s Almedalen Week.”

The purpose of the roundtable discussion was to raise awareness about Flemingsberg’s development in life science and create a platform for the exchange of experiences. We shared valuable insights on how Flemingsberg can become one of Sweden’s most significant centers for education, research, and creativity. A discussion that we hope will continue even after Almedalen.

Watch our film with interviews and a summary of the discussion.

A Pitch Workshop for Entrepreneurs and Innovators in Flemingsberg

Earlier this spring, the Flemingsberg Science Foundation hosted a pitch workshop aimed at supporting entrepreneurs and innovators with promising ideas in Flemingsberg to elevate their concepts to the next level. This workshop coincided with our prestigious competition, Flemingsberg Science Award.

NextCell Pharma: A Decade at the Forefront of the Stem Cell Revolution

For the past ten years, NextCell Pharma has been developing cell therapies for autoimmune and inflammatory diseases, operating Sweden's largest stem cell biobank through its subsidiary, Cellaviva, and conducting five clinical trials. They celebrate this milestone by launching their third subsidiary, QVance.

In Flemingsberg, we cure diseases that were previously considered incurable

Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.

Go to Top